Skip to Content

6,692 Results Found

  • Article
  • Open Access
13 Citations
5,881 Views
11 Pages

Elucidation of Inverse Agonist Activity of Bilastine

  • Hiroyuki Mizuguchi,
  • Tomoharu Wakugawa,
  • Hisato Sadakata,
  • Seiichiro Kamimura,
  • Mai Takemoto,
  • Tomomi Nakagawa,
  • Masami Yabumoto,
  • Yoshiaki Kitamura,
  • Noriaki Takeda and
  • Hiroyuki Fukui

H1-antihistamines antagonize histamine and prevent it from binding to the histamine H1 receptor (H1R). Some of them also act as inverse agonists, which are more potent than pure antagonists because they suppress the constitutive H1R activity. Bilasti...

  • Article
  • Open Access
8 Citations
3,286 Views
17 Pages

9 March 2023

Cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) are components in the endocannabinoid system that play significant roles in regulating immune responses. There are many agonists for the cannabinoid receptors; however, their effects on T...

  • Article
  • Open Access
858 Views
16 Pages

15 December 2025

Background and Objectives: GLP-1 receptor agonists (GLP-1 RAs; ATC A10BJ) and dual GLP-1/GIP agonist (ATC A10BX16) have expanded rapidly due to strong evidence in type 2 diabetes, obesity and metabolic dysfunction-associated steatotic liver disease (...

  • Article
  • Open Access
7 Citations
3,622 Views
17 Pages

Hits Discovery on the Androgen Receptor: In Silico Approaches to Identify Agonist Compounds

  • Manon Réau,
  • Nathalie Lagarde,
  • Jean-François Zagury and
  • Matthieu Montes

13 November 2019

The androgen receptor (AR) is a transcription factor that plays a key role in sexual phenotype and neuromuscular development. AR can be modulated by exogenous compounds such as pharmaceuticals or chemicals present in the environment, and particularly...

  • Article
  • Open Access
9 Citations
3,088 Views
12 Pages

12 October 2021

Veldoreotide, a somatostatin analogue, binds to the somatostatin receptors (SSTR) 2, 4, and 5. The current aim was to assess its pharmacological activity as an SSTR4 agonist. G-protein signaling was assessed using a fluorescence-based membrane potent...

  • Article
  • Open Access
44 Citations
6,949 Views
15 Pages

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy

  • Eun-Jin Go,
  • Hannah Yang,
  • Hong Jae Chon,
  • DaSom Yang,
  • WonHyoung Ryu,
  • Dong-Hyun Kim,
  • Dong Keun Han,
  • Chan Kim and
  • Wooram Park

26 October 2020

Recently, cancer immunotherapy has received attention as a viable solution for the treatment of refractory tumors. However, it still has clinical limitations in its treatment efficacy due to inter-patient tumor heterogeneity and immunosuppressive tum...

  • Review
  • Open Access
17 Citations
32,146 Views
38 Pages

Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment

  • Rui Salvador,
  • Carla Guimarães Moutinho,
  • Carla Sousa,
  • Ana Ferreira Vinha,
  • Márcia Carvalho and
  • Carla Matos

12 March 2025

This review addresses the role of semaglutide (SMG), a GLP-1 receptor agonist, in the treatment of obesity and its related comorbidities. Originally developed for type 2 diabetes (DM2), SMG has shown significant efficacy in weight reduction, with sup...

  • Article
  • Open Access
1 Citations
3,462 Views
14 Pages

Effects of Paired Associative Stimulation on Cortical Plasticity in Agonist–Antagonist Muscle Representations

  • Makoto Suzuki,
  • Kazuo Saito,
  • Yusuke Maeda,
  • Kilchoon Cho,
  • Naoki Iso,
  • Takuhiro Okabe,
  • Takako Suzuki and
  • Junichi Yamamoto

Paired associative stimulation (PAS) increases and decreases cortical excitability in primary motor cortex (M1) neurons, depending on the spike timing-dependent plasticity, i.e., long-term potentiation (LTP)- and long-term depression (LTD)-like plast...

  • Article
  • Open Access
1 Citations
4,071 Views
11 Pages

Cannabielsoin (CBE), a CBD Oxidation Product, Is a Biased CB1 Agonist

  • Mehdi Haghdoost,
  • Scott Young,
  • Matthew Roberts,
  • Caitlyn Krebs and
  • Marcel O. Bonn-Miller

Cannabielsoin (CBE) is primarily recognized as an oxidation byproduct of cannabidiol (CBD) and a minor mammalian metabolite of CBD. The pharmacological interactions between CBE and cannabinoid receptors remain largely unexplored, particularly with re...

  • Article
  • Open Access
12 Citations
7,444 Views
13 Pages

Three-Dimensional Common-Feature Hypotheses for Octopamine Agonist 1-Arylimidazolidine-2-Thiones

  • Akinori Hirashima,
  • Masako Morimoto,
  • Hiroto Ohta,
  • Eiichi Kuwano,
  • Eiji Taniguchi and
  • Morifusa Eto

28 February 2002

Three-dimensional pharmacophore hypotheses were built from a set of 10 octopamine (OA) agonist 1-arylimidazole-2(3H)-thiones (AIHTs) and 1-arylimidazolidine-2-thiones (AITs). Among the ten common-featured models generated by program Catalyst/HipHop,...

  • Article
  • Open Access
17 Citations
5,443 Views
18 Pages

Identification of a Novel PPAR-γ Agonist through a Scaffold Tuning Approach

  • Hyo Jin Gim,
  • Yong-Sung Choi,
  • Hua Li,
  • Yoon-Jung Kim,
  • Jae-Ha Ryu and
  • Raok Jeon

4 October 2018

Peroxisome proliferator-activated receptors (PPARs) are important targets in metabolic diseases including obesity, metabolic syndrome, diabetes, and non-alcoholic fatty liver disease. Recently, they have been highlighted as attractive targets for the...

  • Article
  • Open Access
6 Citations
3,581 Views
19 Pages

Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas

  • Daniela Modena,
  • Maria Luisa Moras,
  • Giovanni Sandrone,
  • Andrea Stevenazzi,
  • Barbara Vergani,
  • Pooja Dasgupta,
  • Andrea Kliever,
  • Sebastian Gulde,
  • Alessandro Marangelo and
  • Christian Steinkühler
  • + 5 authors

30 June 2023

Somatostatin receptor (SSTR) agonists have been extensively used for treating neuroendocrine tumors. Synthetic therapeutic agonists showing selectivity for SSTR2 (Octreotide) or for SSTR2 and SSTR5 (Pasireotide) have been approved for the treatment o...

  • Article
  • Open Access
15 Citations
6,520 Views
19 Pages

23 March 2023

The stimulator-of-interferon-gene (STING) protein is involved in innate immunity. The drug DMXAA (5,6-dimethylxanthenone-4-acetic acid) proved to be a potent murine-STING (mSTING) agonist but had little effect on human-STING (hSTING). In this paper,...

  • Article
  • Open Access
6 Citations
4,753 Views
12 Pages

Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates

  • Parima Udompholkul,
  • Carlo Baggio,
  • Luca Gambini,
  • Yu Sun,
  • Ming Zhao,
  • Robert M. Hoffman and
  • Maurizio Pellecchia

17 June 2021

We recently reported on a potent synthetic agent, 135H11, that selectively targets the receptor tyrosine kinase, EphA2. While 135H11 possesses a relatively high binding affinity for the ligand-binding domain of EphA2 (Kd~130 nM), receptor activation...

  • Article
  • Open Access
1 Citations
4,509 Views
8 Pages

26 September 2019

The identification and three step synthesis of 3-O-protocatechuoylceanothic acid, a novel and natural GPR120 agonist, is described. This ceanothane-type triterpenoid was identified from the components of Ziziphus jujuba roots and was found to be a ne...

  • Brief Report
  • Open Access
1 Citations
3,008 Views
11 Pages

Comparative In Vitro Study of Various α2-Adrenoreceptor Agonist Drugs for Ticagrelor Reversal

  • Guillaume Porta Bonete,
  • Anne Godier,
  • Pascale Gaussem,
  • Tiphaine Belleville-Rolland,
  • Alexandre Leuci,
  • Sonia Poirault-Chassac,
  • Christilla Bachelot-Loza and
  • Anne-Céline Martin

16 March 2020

Ticagrelor, an antiplatelet adenosine diphosphate (ADP)-P2Y12 receptor antagonist, increases the risk of bleeding. Its management is challenging because platelet transfusion is ineffective and no specific antidote is currently available. Epinephrine,...

  • Review
  • Open Access
510 Views
20 Pages

31 January 2026

Stem-cell differentiation technologies have traditionally relied on recombinant growth factors, cytokines, and morphogens to initiate and guide lineage specification toward clinically relevant cell types. These approaches have enabled substantial pro...

  • Article
  • Open Access
4 Citations
3,787 Views
14 Pages

7 November 2023

Beta-agonists (β-agonists) in meat products in one’s diet raise concerns about the possibility of foodborne illness. It may also lead to discomfort, such as headaches and occasional irregular heartbeats, which might be linked to a heighten...

  • Review
  • Open Access
9 Citations
3,799 Views
9 Pages

29 May 2022

Objective: Prolactinomas are the most common type of functional, hormone-secreting pituitary adenomas that account for about 40% of total pituitary adenomas. Typical clinical presentations include loss of menstrual periods (amenorrhea) and galactorrh...

  • Article
  • Open Access
5 Citations
3,144 Views
13 Pages

Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine

  • Darya Pon`kina,
  • Sergey Kuranov,
  • Mikhail Khvostov,
  • Nataliya Zhukova,
  • Yulia Meshkova,
  • Mariya Marenina,
  • Olga Luzina,
  • Tatyana Tolstikova and
  • Nariman Salakhutdinov

3 January 2023

Free fatty acid receptor-1 (FFAR1) is one of the possible therapeutic targets in the search for new hepatoprotective drugs. FFAR1 agonists were found to have hypolipidemic, antifibrotic, anti-inflammatory, antiproliferative and antioxidant effects in...

  • Review
  • Open Access
4 Citations
2,761 Views
23 Pages

Translational Experimental Basis of Indirect Adenosine Receptor Agonist Stimulation for Bone Regeneration: A Review

  • Quinn T. Ehlen,
  • Nicholas A. Mirsky,
  • Blaire V. Slavin,
  • Marcelo Parra,
  • Vasudev Vivekanand Nayak,
  • Bruce Cronstein,
  • Lukasz Witek and
  • Paulo G. Coelho

Bone regeneration remains a significant clinical challenge, often necessitating surgical approaches when healing bone defects and fracture nonunions. Within this context, the modulation of adenosine signaling pathways has emerged as a promising thera...

  • Review
  • Open Access
742 Views
60 Pages

Incretin-Based Multi-Agonist Therapies for Type 2 Diabetes Mellitus and Obesity: Mechanisms, Clinical Efficacy, and Future Directions

  • Dhruba Podder,
  • Olivia Stala,
  • Atikul Miah,
  • Abigail Agyapong,
  • Madeline Elizabeth Moore,
  • Rahim Hirani,
  • Danielle Diegisser,
  • Victor Garcia and
  • Mill Etienne

Type 2 diabetes mellitus (T2DM) and obesity affect hundreds of millions of adults worldwide and represent leading drivers of cardiovascular disease, chronic kidney disease, and escalating healthcare expenditures. Incretin-based therapies have fundame...

  • Review
  • Open Access
9 Citations
3,519 Views
27 Pages

Paper-Based Fluidic Sensing Platforms for β-Adrenergic Agonist Residue Point-of-Care Testing

  • Hongzhi Luo,
  • Shan Liu,
  • Lina Shi,
  • Zhu Li,
  • Qianwen Bai,
  • Xiaoxin Du,
  • Lijun Wang,
  • He Zha and
  • Chenzhong Li

12 July 2022

The illegal use of β-adrenergic agonists during livestock growth poses a threat to public health; the long-term intake of this medication can cause serious physiological side effects and even death. Therefore, rapid detection methods for β-...

  • Article
  • Open Access
12 Citations
4,986 Views
16 Pages

Identification of the Natural Steroid Sapogenin Diosgenin as a Direct Dual-Specific RORα/γ Inverse Agonist

  • Patrik F. Schwarz,
  • Alexander F. Perhal,
  • Lucia N. Schöberl,
  • Martin M. Kraus,
  • Johannes Kirchmair and
  • Verena M. Dirsch

The steroid sapogenin diosgenin is a well-known natural product with a plethora of described pharmacological activities including the amelioration of T helper 17 (Th17)-driven pathologies. However, the exact underlying mode of action of diosgenin lea...

  • Communication
  • Open Access
7 Citations
3,833 Views
10 Pages

High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist

  • Guangyao Lin,
  • Yang Feng,
  • Xiaoqing Cai,
  • Caihong Zhou,
  • Lijun Shao,
  • Yan Chen,
  • Linhai Chen,
  • Qing Liu,
  • Qingtong Zhou and
  • Ming-Wei Wang
  • + 2 authors

11 December 2021

Relaxin/insulin-like family peptide receptor 3 (RXFP3) belongs to class A G protein-coupled receptor family. RXFP3 and its endogenous ligand relaxin-3 are mainly expressed in the brain with important roles in the regulation of appetite, energy metabo...

  • Article
  • Open Access
4 Citations
3,889 Views
13 Pages

GB83, an Agonist of PAR2 with a Unique Mechanism of Action Distinct from Trypsin and PAR2-AP

  • Yunkyung Heo,
  • Eunhee Yang,
  • Yechan Lee,
  • Yohan Seo,
  • Kunhi Ryu,
  • Hyejin Jeon and
  • Wan Namkung

13 September 2022

Protease-activated receptor 2 (PAR2) is a G-protein-coupled receptor (GPCR) activated by proteolytic cleavage of its N-terminal domain. Once activated, PAR2 is rapidly desensitized and internalized by phosphorylation and β-arrestin recruitment....

  • Article
  • Open Access
792 Views
16 Pages

Bioactive Glycosylated Flavonoids Exhibiting LXR Agonist Activity from a Lauraceae Colombian Species

  • Juanita Pulido-Teuta,
  • Fabian López-Vallejo,
  • Adrián G. Sandoval-Hernández,
  • Carlos-Eduardo Narváez-Cuenca and
  • Mónica Avila-Murillo

22 October 2025

Lipid metabolism is a vital biological process essential for human health, encompassing key pathways necessary for the survival and homeostasis of all organisms. Liver X Receptors (LXRs) are extensively acknowledged as pivotal regulators of lipid hom...

  • Article
  • Open Access
11 Citations
3,227 Views
14 Pages

Anticancer Effect of STING Agonist-Encapsulated Liposomes on Breast Cancer

  • Jibing Zhang,
  • Xiao Cui,
  • Yujiao Huang,
  • Xiangdong Xu,
  • Changshun Feng and
  • Jun Li

26 April 2023

Breast cancer is one of the most common cancers worldwide, posing a serious threat to human health. Recently, innate immunity has become a widely discussed topic in antitumor research. The STING pathway is an important component of innate immunity, a...

  • Review
  • Open Access
36 Citations
10,436 Views
17 Pages

Adenosine is an endogenous modulator exerting its functions through the activation of four adenosine receptor (AR) subtypes, termed A1, A2A, A2B and A3, which belong to the G protein-coupled receptor (GPCR) superfamily. The human A3AR (hA3AR) subtype...

  • Article
  • Open Access
17 Citations
5,382 Views
12 Pages

11 September 2021

Antipruritic effects of kappa opioid receptor (KOR) agonists have been shown in rodent models of acute and chronic scratching (itchlike behavior). Three KOR agonists, nalfurafine, difelikefalin, and nalbuphine, are in clinical studies for antipruriti...

  • Article
  • Open Access
7 Citations
8,883 Views
12 Pages

Recombinant Expression and Stapling of a Novel Long-Acting GLP-1R Peptide Agonist

  • Sam Lear,
  • Hyosuk Seo,
  • Candy Lee,
  • Lei Lei,
  • Zaid Amso,
  • David Huang,
  • Huafei Zou,
  • Zhihong Zhou,
  • Vân T. B. Nguyen-Tran and
  • Weijun Shen

Owing to their pleiotropic metabolic benefits, glucagon-like peptide-1 receptor (GLP-1R) agonists have been successfully utilized for treating metabolic diseases, such as type 2 diabetes and obesity. As part of our efforts in developing long-acting p...

  • Article
  • Open Access
11 Citations
5,351 Views
13 Pages

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists

  • Parthasaradhireddy Tanguturi,
  • Vibha Pathak,
  • Sixue Zhang,
  • Omar Moukha-Chafiq,
  • Corinne E. Augelli-Szafran and
  • John M. Streicher

5 November 2021

The delta opioid receptor (DOR) is a crucial receptor system that regulates pain, mood, anxiety, and similar mental states. DOR agonists, such as SNC80, and DOR-neutral antagonists, such as naltrindole, were developed to investigate the DOR in vivo a...

  • Article
  • Open Access
2 Citations
3,061 Views
17 Pages

21 February 2023

Retinoid X receptor (RXR) agonists, which activate the RXR nuclear receptor, are effective in multiple preclinical cancer models for both treatment and prevention. While RXR is the direct target of these compounds, the downstream changes in gene expr...

  • Article
  • Open Access
6 Citations
3,038 Views
9 Pages

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice

  • Kensaku Nakai,
  • Takuya Misugi,
  • Kohei Kitada,
  • Yasushi Kurihara,
  • Mie Tahara,
  • Akihiro Hamuro,
  • Akemi Nakano,
  • Masayasu Koyama,
  • Yukimi Kira and
  • Daisuke Tachibana

Thrombopoietin receptor agonists (TPO-RAs) are an effective treatment for refractory immune thrombocytopenia (ITP). However, the use of TPO-RAs is limited for ITP in pregnant women due to concerns about fetal toxicity. In this study, we examined the...

  • Article
  • Open Access
9 Citations
3,233 Views
16 Pages

Adenosine A3 Receptor (A3AR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice

  • Silvia Sgambellone,
  • Silvia Marri,
  • Stefano Catarinicchia,
  • Alessandro Pini,
  • Dilip K. Tosh,
  • Kenneth A. Jacobson,
  • Emanuela Masini,
  • Daniela Salvemini and
  • Laura Lucarini

1 November 2022

Adenosine receptors (ARs) are involved in the suppression and development of inflammatory and fibrotic conditions. Specifically, AR activation promotes differentiation of lung fibroblasts into myofibroblasts, typical of a fibrotic event. Pulmonary fi...

  • Article
  • Open Access
14 Citations
6,230 Views
18 Pages

9 March 2022

The α7 nicotinic acetylcholine receptor (nAChR) is widely distributed in the central and peripheral nervous systems and is closely related to a variety of nervous system diseases and inflammatory responses. The α7 nAChR subtype plays a vi...

  • Article
  • Open Access
8 Citations
3,654 Views
14 Pages

27 November 2018

The pharmaceutical compounds that modulate pluripotent stem cell (PSC) identity and function are increasingly adopted to generate qualified PSCs and their derivatives, which have promising potential in regenerative medicine, in pursuit of more accura...

  • Article
  • Open Access
10 Citations
3,739 Views
15 Pages

Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron

  • Xiaodi Zhao,
  • Dohee Ahn,
  • Gibeom Nam,
  • Jihee Kwon,
  • Songyi Song,
  • Min Ji Kang,
  • Hyejin Ahn and
  • Sang J. Chung

13 November 2023

Crocin, a glycoside of crocetin, has been known as the principal component responsible for saffron’s antidiabetic, anticancer, and anti-inflammatory effects. Crocetin, originating from the hydrolytic cleavage of crocin in biological systems, wa...

  • Article
  • Open Access
8 Citations
3,313 Views
12 Pages

Preparation of a First 18F-Labeled Agonist for M1 Muscarinic Acetylcholine Receptors

  • Boris D. Zlatopolskiy,
  • Felix Neumaier,
  • Till Rüngeler,
  • Birte Drewes,
  • Niklas Kolks and
  • Bernd Neumaier

23 June 2020

M1 muscarinic acetylcholine receptors (mAChRs) are abundant in postsynaptic nerve terminals of all forebrain regions and have been implicated in the cognitive decline associated with Alzheimer’s disease and other CNS pathologies. Consequently,...

  • Article
  • Open Access
14 Citations
2,953 Views
29 Pages

Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans

  • Joshua A. Lutz,
  • Agnieszka Sulima,
  • Eugene S. Gutman,
  • Eric W. Bow,
  • Dan Luo,
  • Sophia Kaska,
  • Thomas E. Prisinzano,
  • Carol A. Paronis,
  • Jack Bergman and
  • Kenner C. Rice
  • + 3 authors

15 June 2023

All possible diastereomeric C9-hydroxymethyl-, hydroxyethyl-, and hydroxypropyl-substituted 5-phenylmorphans were synthesized to explore the three-dimensional space around the C9 substituent in our search for potent MOR partial agonists. These compou...

  • Article
  • Open Access
6 Citations
3,275 Views
10 Pages

Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer

  • Changcai Teng,
  • Xiongyan Meng,
  • Yeqin Hu,
  • Hongzhao Mao,
  • Huiting Li,
  • Jing Yang,
  • Tiantian Sun,
  • Shuai Meng and
  • Chengli Zong

13 December 2022

Small synthetic TLR7/8-agonists can be used as vaccine adjuvants to enhance cell and humoral-mediated immune responses to specific antigens. Despite their potency, after local injection they can be dispersed to undesired body parts causing high react...

  • Article
  • Open Access
9 Citations
4,954 Views
19 Pages

Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models

  • Andreas Jekle,
  • Santosh Kumar Thatikonda,
  • Ruchika Jaisinghani,
  • Suping Ren,
  • April Kinkade,
  • Sarah K. Stevens,
  • Antitsa Stoycheva,
  • Vivek K. Rajwanshi,
  • Caroline Williams and
  • Leonid Beigelman
  • + 8 authors

13 November 2023

Stimulator of interferon genes (STING) agonists have shown potent anti-tumor efficacy in various mouse tumor models and have the potential to overcome resistance to immune checkpoint inhibitors (ICI) by linking the innate and acquired immune systems....

  • Article
  • Open Access
2 Citations
2,844 Views
16 Pages

Structure–Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074

  • George Amato,
  • Vineetha Vasukuttan,
  • Danni Harris,
  • Lucas Laudermilk,
  • Jennifer Lucitti,
  • Scott Runyon and
  • Rangan Maitra

2 September 2022

Selective modulation of peripheral cannabinoid receptors (CBRs) has potential therapeutic applications in medical conditions, including obesity, diabetes, liver diseases, GI disorders and pain. While there have been considerable efforts to produce se...

  • Review
  • Open Access
7 Citations
3,625 Views
21 Pages

21 October 2021

Biphalin, one of the opioid agonists, is a dimeric analog of enkephalin with a high affinity for opioid receptors. Opioid receptors are widespread in the central nervous system and in peripheral neuronal and non-neuronal tissues. Hence, these recepto...

  • Article
  • Open Access
1 Citations
2,425 Views
17 Pages

1 August 2023

Modified opioid agonist therapy (OAT) guidelines that were initially introduced during the COVID-19 pandemic allow prescribers to increase the number of take-home doses to fulfill their need for physical distancing and prevent treatment discontinuati...

  • Article
  • Open Access
1,242 Views
32 Pages

JP-14: A Trace Amine-Associated Receptor 1 Agonist with Anti-Metabolic Disorder Potential

  • Monika Marcinkowska,
  • Joanna Sniecikowska,
  • Monika Głuch-Lutwin,
  • Barbara Mordyl,
  • Marek Bednarski,
  • Adam Bucki,
  • Michał Sapa,
  • Monika Kubacka,
  • Agata Siwek and
  • Magdalena Kotańska
  • + 3 authors

15 October 2025

TAAR1 agonists have emerged as promising therapeutic agents capable of modulating glucose homeostasis, enhancing insulin secretion and suppressing appetite, making them attractive candidates for the treatment of obesity and related metabolic disorder...

  • Article
  • Open Access
4 Citations
2,823 Views
15 Pages

Targeted Delivery of STING Agonist via Albumin Nanoreactor Boosts Immunotherapeutic Efficacy against Aggressive Cancers

  • Zhijun Miao,
  • Xue Song,
  • Anan Xu,
  • Chang Yao,
  • Peng Li,
  • Yanan Li,
  • Tao Yang and
  • Gang Shen

Background: Activating the cytosolic innate immune sensor, the cGAS-STING pathway, holds great promise for enhancing antitumor immunity, particularly in combination with immune checkpoint inhibitors (ICIs). However, the clinical application of STING...

  • Article
  • Open Access
17 Citations
4,174 Views
18 Pages

CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice

  • Xiaojie Liu,
  • Hao Yu,
  • Bixuan Chen,
  • Vladislav Friedman,
  • Lianwei Mu,
  • Thomas J. Kelly,
  • Gonzalo Ruiz-Pérez,
  • Li Zhao,
  • Xiaowen Bai and
  • Qing-song Liu
  • + 1 author

In addition to motor dysfunction, patients with Parkinson’s disease (PD) are often affected by neuropsychiatric disorders, such as anxiety and depression. In animal models, activation of the endocannabinoid (eCB) system produces anxiolytic and...

  • Article
  • Open Access
4 Citations
4,031 Views
20 Pages

8 October 2021

Background: Cheonggukjang is a traditional fermented soybean paste that is mostly consumed in Korea. However, the biological activities of Cheonggukjang specific compounds have not been studied. Thus, we aimed to discover a novel dual agonist for PPA...

  • Article
  • Open Access
47 Citations
14,320 Views
25 Pages

A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain

  • Arden Perkins,
  • Jessica L. Phillips,
  • Nancy I. Kerkvliet,
  • Robert L. Tanguay,
  • Gary H. Perdew,
  • Siva K. Kolluri and
  • William H. Bisson

17 October 2014

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that regulates the expression of a diverse group of genes. Exogenous AHR ligands include the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which is...

of 134